Janus Henderson Biotech Innovation Master Fund Ltd is 10% Owner at ARCA biopharma, Inc. (ABIO). They have made 2 open-market trades across 1 company since 2024, most recently 2024-08-16.
CIK 0002030299
2 open-market purchases totalling $2.7M since 2024, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ABIO | 2,117,213 | $5.1M |
Shares reported on the most recent Form 4, priced at the 2024-08-20 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.